In animal models, the OAT1/3, OCT2, and BCRP expressions are decreased under the pathological condition, whereas MDR1 and MRP2/4 expressions are not affected by hyperuricemia (Nishizawa et al., 2019; Le et al., 2020). This evidence concerns the gene SLC22A6 and hyperuricemia.